Michael Joseph Boyer
Michael Joseph Boyer publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #121,568 of 7,710,434 ranked researchers
- Rank in Australia
- #4,072 of 140,210
- Works
- 609
- Citations
- 52k
- Citations per work
- 85.7
What does Michael Joseph Boyer research?
Michael Joseph Boyer's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences32252.9%
- Medicine32252.9%
- Everything else19331.7%
- Life Sciences9415.4%
- 1Pulmonary and Respiratory Medicine26% of their works
- 2Oncology24% of their works
- 3Molecular Biology8% of their works
- 4Immunology4% of their works
- 5Cancer Research4% of their works
- 6Surgery3% of their works
Research topics
Which keywords describe Michael Joseph Boyer's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Genomic Profiles and Small-Cell Lung Cancer.
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Mutational Signatures
- KRAS Mutations
- PD-1 and PD-L1
- Lung Cancer
- Small-Cell Lung Cancer
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Genomic Profiles
- CT Screening
- Immune Checkpoint Blockade
- Cetuximab
- Cancer Genomics
- BAP1 mutations
- Malignant Pleural Mesothelioma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Targeted Therapy2993 topics
- Clinical Trials2712 topics
- Chemotherapy2123 topics
- ALK Inhibitors1811 topic
- EGFR Mutations1811 topic
- Immunotherapy1172 topics
- Genomic Profiles901 topic
- Small-Cell Lung Cancer901 topic
- CT Screening831 topic
- Lung Cancer831 topic
- Immune Checkpoint Blockade711 topic
- PD-1 and PD-L1711 topic
- Cetuximab391 topic
- KRAS Mutations391 topic
- Cancer Genomics281 topic
- Mutational Signatures281 topic
- BAP1 mutations271 topic
- Chemotherapy-Induced Peripheral Neuropathy271 topic
- Malignant Pleural Mesothelioma271 topic
- Taxanes271 topic
Where does Michael Joseph Boyer work?
Michael Joseph Boyer's main affiliation in the publication record is Chris O’Brien Lifehouse, Australia.
How many publications and citations does Michael Joseph Boyer have?
OpenAlex counts 609 works and 52,181 citations for Michael Joseph Boyer, an h-index of 80, ranking #121,568 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Joseph Boyer. Posts are plain text and can be reported.